Ledger.Open graph →
SEC Form D · filed January 18, 2017

Vividion Therapeutics, Inc

Offering
$50.5M
Sold
$20.2M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
PRINCETON, NJ
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (9)

John K. Park · Princeton, NJExecBenjamin K. Cravatt · Princeton, NJDirectorJohn K. Clarke · Princeton, NJExec · DirectorJeffrey G. Galentine · Columbia, MDExecEnterprise Community Investment, Inc · Columbia, MDExec · DirectorEnterprise Fund Manager II, LLC · Columbia, MDDirectorScott J. Nolan · San Francisco, CAExec · DirectorFrank J. Costa, Md · Harmony, PAExecAnthony J. Tomasello · Harmony, PADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗